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Abstract
Mycobacterium tuberculosis (Mtb) is the causative agent of tuberculosis, one of
the top ten causes of death worldwide. One of the genes upregulated in Mtb during
macrophage infection is rv2633c, but the structure and function of its gene product
remain unknown. Preliminary research has indicated that Rv2633c is a hemerythrin-like
protein that exhibits catalase activity and binds two iron atoms using an HHE domain.
Additionally, Rv2633c appears to exist as a dimer. The purpose of this project is to
identify specific residues outside of the HHE domain that contribute to the protein’s ironbinding ability and/or catalase activity, and to determine whether residues on the C
terminus are required for dimerization. Conserved residues D37, E42, and E95 were
selected due to their proximity in the amino acid sequence to the HHE domain. Each
residue was mutated to alanine using site-directed mutagenesis and the mutations were
confirmed using Sanger sequencing. The E95A mutant and the C-terminal truncation
mutant were expressed in Escherichia coli using the T7 expression system and purified
using affinity chromatography. While wild-type Rv2633c eluted as a soluble protein, the
C-terminal truncation mutant was not soluble, indicating that the C terminus may be
required for Rv2633c folding. The E95A mutant eluted as a soluble protein, but may have
lower iron content than wild-type Rv2633c, indicating that this glutamic acid residue
could contribute to iron-binding, despite being outside the HHE domain.
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INTRODUCTION
Mycobacterium tuberculosis
Mycobacterium tuberculosis (Mtb) is a rod-shaped species of bacteria that causes
tuberculosis disease (TB). TB is one of the top ten causes of death worldwide, killing 1.3
million people in 2017, and latently infecting one fourth of the world’s population [1].
Despite research efforts dating back to the 19th century, a highly effective vaccine for Mtb
has not been developed [1]. TB is a health concern in developing countries, with 60% of
cases originating in India, Indonesia, China, Nigeria, Pakistan, and South Africa [1]. A
significant challenge in eradicating TB remains the discrepancy between the predicted
number of cases that occur and the number of cases that are diagnosed and reported.
TB is spread through the air through coughing, sneezing, and speaking. Droplet
nuclei containing Mtb enter the upper respiratory system, and are cleared in most cases
before reaching the lower respiratory system. If Mtb does reach the lung mucosa, it is
engulfed by resident macrophages through phagocytosis and becomes enclosed in the
phagosome. Typically, the phagosome fuses with the lysosome, a harsh intracellular
compartment with low pH. When these two compartments fuse, they form the
phagolysosome, which degrades the bacteria within. However, Mtb is able to prevent
fusion of the phagosome to the lysosome [2]. This ability allows Mtb to replicate inside
host macrophages.
Oxidative Stress in Mtb
One way that Mtb may have evolved to survive inside the macrophage is through
resisting oxidative stress [3]. Oxidative stress is caused by reactive oxygen species
produced during the immune response such as superoxide (O2-), peroxide (H2O2),
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hypochlorite (HClO), hydroxyl radicals, and peroxynitrite (ONOO-) [3]. These reactive
oxygen and nitrogen species damage bacterial DNA, proteins, and lipids. A common
bacterial defense against reactive oxygen species is the catalase class of enzymes, which
converts peroxide into water and oxygen [3]. Mtb contains a well-studied catalase, KatG,
which neutralizes the peroxides generated by NADPH oxidase [4].
Hemerythrin-like proteins
Contrary to their name, hemerythrin-like proteins do not contain heme. Instead,
hemerythrin-like proteins are characterized by the presence of an HHE domain, which
consists of two histidine residues and a glutamic acid residue, often distributed over two
separate alpha helices [5, 6]. The HHE domain in hemerythrin-like proteins commonly
binds two iron atoms [7, 8]. Hemerythrin-like proteins typically bind oxygen, and are
present in a wide variety of bacteria. Some hemerythrin-like proteins contain additional
signal transduction domains, indicating that these proteins play diverse roles [9].
Rv2633c
Rv2633c is a gene found in Mtb that is upregulated as Mtb infects the macrophage
[10, 11]. Additionally, rv2633c is upregulated in vitro when Mtb is grown in acidic
conditions [12]. Species of Mycobacteria that contain the rv2633c gene tend to be more
pathogenic, indicating that rv2633c may contribute to virulence [13]. Furthermore, when
rv2633c is inactivated by a transposon insertion, Mtb is attenuated when injected into the
tail vein of a mouse model [14]. Previous research has shown that Rv2633c exhibits
catalase activity with a kcat of 1475 s-1 and a Km of 10.1±1.7 mM [13]. Together, these
studies indicate that Rv2633c may contribute to Mtb pathogenicity by combating reactive
oxygen species within the macrophage.
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While the structure of Rv2633c remains unknown, it contains an HHE domain,
and has been shown to bind two iron atoms in a manner consistent with other
Hemerythrin-like proteins [13]. However, unlike hemerythrin-like proteins, Rv2633c
exhibits catalase activity instead of reversibly binding oxygen. Furthermore, while
hemerythrin-like proteins commonly form octamers, Rv2633c has been shown to migrate
through a size-exclusion column as a dimer [13]. The unique combination of an HHE
domain and catalase activity in Rv2633c makes this protein the first example of a nonheme di-iron catalase.
The purpose of this project is to identify specific residues outside of the HHE
domain that contribute to the protein’s iron-binding ability and catalase activity, and to
determine whether residues on the C terminus are required for the dimerization of
Rv2633c.
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MATERIALS AND METHODS
Design of Rv2633c Mutants
To determine residues outside of the HHE domain that affect iron-binding in
Rv2633c, highly conserved residues were chosen based on their proximity to the HHE
domain in the primary amino acid sequence of Rv2633c. Based on this method, residues
D37, E42, and E95 were chosen for mutation. Each residue was mutated to alanine,
because aspartic acid (D) and glutamic acid (E) are highly charged, whereas alanine is
neutral. This mutation preserves the structure of the protein while eliminating any
functionality due to the charge of the amino acid side chain.
To determine whether the C terminus of Rv2633c is necessary for dimerization of
the protein, a C-terminal truncation mutant was constructed. The exact residues to delete
were determined by analyzing the SWISS-MODEL predicted structure of Rv2633c. The
predicted structure consisted of four alpha helices arranged in a barrel shape around a diiron center, with a fifth alpha helix positioned away from the barrel on the C-terminal
end. The C-terminal truncation mutant was generated by deleting this fifth alpha helix,
corresponding to residues I122-I161. The 6XHis tag and stop codon were moved to the
end of the fourth alpha helix, thus shortening Rv2633c.
Construction of Rv2633c Mutants
A pET23a vector was used for cloning and generation of Rv2633c mutants. Each
point mutant was generated using ‘Round the Horn mutagenesis, a polymerase chain
reaction (PCR) based technique [15]. This method entailed designing a forward primer
that annealed immediately downstream of the mutation site, and a reverse primer that
contained the desired mutation. The C-terminal truncation (ΔI122-I161) mutant was
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generated by designing a forward primer that annealed to the 6XHis tag and stop codon,
and a reverse primer that annealed to the last amino acid in the fourth alpha helix. This
primer placement ensured that the DNA between the forward and reverse primers was
deleted, removing residues I122-I161 from the C-terminal end of Rv2633c.
Prior to performing PCR, each forward and reverse primer was phosphorylated
using PNK, 100 mM ATP, and 10X PNK buffer. This step is necessary for the ligation of
the linear PCR product because restriction enzymes are not used in ‘Round the Horn
mutagenesis.
After phosphorylating each primer, PCR was performed to introduce each desired
mutation and amplify the mutant DNA. Each PCR was conducted with 25 μL deionized
water, 10 μL 5X Q5 buffer, 10 μL GC enhancer, 1.5 μL phosphorylated forward and
reverse primers, 1 μL 10 mM dNTPs, 40 ng plasmid template, and 0.5 μL Q5 DNA
polymerase. The reaction was heated to 98°C for one minute, 96°C for 30 seconds, 60°C
for 30 seconds, and 72°C for 2.5 minutes. This cycle was repeated 28 times before
cooling to 18°C.
Success of the PCR was determined by 0.8% agarose gel electrophoresis. Each
well was loaded with 5 μL PCR product and 2 μL 6X loading buffer. The gel was
submerged in 1X Tris-Acetate EDTA buffer and run at constant volts (100 V) for 30
minutes. The gel was imaged using ultraviolet light. Presence of a 4 kb band indicated
PCR success.
Confirmation of Rv2633c Mutants
Mutant PCR products were purified using crystal violet agarose gel extraction.
Each purified linear PCR product was ligated to form circular DNA by incubating 4 μL
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PCR product with 4.6 μL deionized water, 1 μL 10X T4 DNA ligase buffer, and 0.4 μL
T4 DNA ligase. The reaction was incubated at room temperature for 10 minutes.
The ligated PCR product was transformed into NEB 5-alpha E. coli using the
NEB protocol for heat shock transformation. Transformed cells were plated on LBLennox agar supplemented 100 μg/mL ampicillin to select for cells containing the
pET23a plasmid.
Plasmids containing Rv2633c mutants were prepared for sequencing by alkaline
lysis (miniprep). A 10 μL solution of 50% plasmid in deionized water was shipped to
GeneWiz for Sanger sequencing.
Purification of Rv2633c Mutants
Each verified mutant was transformed into Lemo21(DE3) (New England Biolabs)
using the protocol provided for heat shock transformation. Transformed cells were plated
on LB-Lennox supplemented with 0.2% glucose, 0.2% glycerol, and 200 μg/mL
ampicillin. The presence of glucose at this concentration prevented the premature
expression of mutant Rv2633c. Glycerol served as a carbon source and alternative to the
amino acids supplied by the tryptone in LB-Lennox. Ampicillin was used to select for
cells containing the pET23a plasmid, but in this case, the concentration of ampicillin was
doubled to ensure that the plasmid is not lost prior to expression and purification. Serial
dilutions of transformed NEB Lemo21(DE3) were plated with 100 μg/mL ampicillin and
200 μg/mL ampicillin, and no noticeable growth difference was observed.
Each mutant was grown at 37°C for 12-16 hours in a liquid culture of LB-Lennox
supplemented with 0.2% glucose, 0.2% glycerol, 1 mM magnesium sulfate, and 200
μg/mL ampicillin. The liquid culture was diluted 1:100 in LB-Lennox supplemented with

6

0.2% glycerol, 1 mM magnesium sulfate, and 200 μg/mL ampicillin. Glucose was
excluded from the media during this stage to allow for maximum expression of mutant
Rv2633c using the T7 expression system.
After 1.5 hours, the temperature of the incubator was reduced to 18°C to assist in
folding of mutant Rv2633c. When the temperature reached 18°C, expression of mutant
Rv2633c was induced with 1 mM IPTG. 500 mg/L Mohr’s salt was added to allow
formation of the iron cofactor. The culture was incubated at 18°C for 7 hours and
harvested immediately after this period by centrifugation at 12,000 x g for 10 minutes at
4°C. Each cell pellet was resuspended in cell wash buffer containing 25 mM Tris and 1
mM EDTA, and centrifuged again at the same specifications.
The washed cell pellet was resuspended in 5 mL lysis buffer containing 25 mM
Tris and 1 mM benzamidine. Lysozyme was added to a concentration of 1 mM, and this
mixture was placed on a rotator for 30 minutes at 4°C. To aid in lysis, chloroform was
added at a final concentration of 10 μL/mL lysate. 0.25 μL Pierce Universal Nuclease
was added to degrade genomic DNA. The resulting lysate was centrifuged at 28,000 x g
for 20 minutes at 4°C to separate soluble protein from insoluble protein.
Cobalt affinity column resin was prepared by centrifugation at 1,000 x g for 5
minutes at 4°C. Damaged beads were removed by decanting the supernatant. Soluble
lysate was added to 2 mL of cobalt resin and placed on a rotator for 30 minutes at 4°C.
Unbound protein was collected by adding the soluble lysate and cobalt resin to a
gravity column and allowing the liquid phase to pass through the column. The column
was washed with 3 column volumes (6 mL) of wash buffer containing 25 mM Tris and
15 mM imidazole. Each wash was collected in a separate conical tube. Bound protein was
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eluted using one column volume of elution buffer containing 25 mM Tris and 300 mM
imidazole.
The protein content of the pre-induction cells, post-induction cells, total lysate,
insoluble lysate, soluble lysate, unbound, wash, and elution samples was determined
using 12% SDS-PAGE. Each SDS-PAGE gel was submerged in 1X Tris-Glycine buffer
and run at constant amps (135 A) for 30-45 minutes. Gels were stained using GelCode
Blue and destained using 10% acetic acid. Elution samples with the highest concentration
of Rv2633c were pooled, and residual imidazole was removed by dialysis into 20 mM
HEPPS, a HEPES-based buffer.
Determination of Mutant Rv2633c Iron Content
The iron content of mutant Rv2633c was determined by UV-vis absorbance
spectrum analysis. The spectrophotometer was blanked using 60 μL 20 mM HEPPS. The
UV absorbance of each Rv2633c sample was measured from 250 nm to 700 nm. Three
samples of dialyzed Rv2633c from each purification were measured and the absorbance
at each wavelength was averaged. The resulting absorbances were graphed in Prism.
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RESULTS
Figure 1: Coordination of iron atoms by HHE domain in hemerythrin-like proteins

The HHE domain of hemerythrin-like proteins commonly coordinates two iron
atoms, as shown above in a previously reported model [13]. Specifically, the iron atoms
are coordinated by the side chains of histidine, aspartic acid, and glutamic acid residues.
Previous research has shown that mutations in residues within the HHE domain result in
loss of the iron cofactor in Rv2633c.

Figure 2: Location of point mutations and truncation mutation relative to the HHE
domain in Rv2633c

Highly conserved, charged amino acids were selected for mutation based on their
proximity to the HHE domain in the sequence of Rv2633c. Here, the HHE domain is
shown in yellow and the amino acids selected for mutation are shown in red. The deleted
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region of the truncation mutant is also shown in red at the C-terminal end of the amino
acid sequence.

Figure 3: SWISS-MODEL Rv2633c structure prediction

Because the structure of Rv2633c remains unknown, SWISS-MODEL was used
to generate a predicted structure. Hypothetical protein NMB1532 from Neisseria
meningitidis was algorithmically chosen by SWISS-MODEL to serve as the structural
template for Rv2633c. Based on the structure of NMB1532, Rv2633c was predicted to
contain four alpha helices arranged in a barrel shape around the di-iron cofactor, shown
as two pink circles inside the barrel, with a fifth alpha helix on the C-terminal end of
Rv2633c positioned outside the barrel. For clarity, this helix is shown in red. This
predicted structure led to the hypothesis that the fifth alpha helix is involved in
dimerization. The C-terminal truncation mutant lacks this fifth alpha helix, corresponding
to residues I122-I161.
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Figure 4: Approximate locations of Rv2633c point mutations based on homology to
NMB1532

From top, the approximate locations of Rv2633c mutations D37A, E42A, and
E95A are shown based on the structure of NMB1532, a protein projected by SWISSMODEL to be structurally similar to Rv2633c. While these locations are only
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approximate, they serve as a rough indicator of the proximity of each mutant amino acid
to the iron cofactor in Rv2633c. It should be noted that the original plan for mutagenesis
was based solely on the primary amino acid sequence and alignments with similar HHE
domain proteins, and not on this modeled structure.

Figure 5: Approximation of Rv2633c C-terminal truncation mutant based on
homology to NMB1532

The approximate portion of Rv2633c that is deleted in the ΔI122-I161 mutant is
modeled here, again using the structure of NMB1532 as a template. The purpose of
creating this mutant is to determine whether the predicted C-terminal alpha helix is
necessary for dimerization in Rv2633c.
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Figure 6: Successful generation of D37A and E42A Rv2633c PCR products

D37A and E42A Rv2633c mutant PCR products were visualized using a 0.8%
agarose gel to confirm successful PCR. From left, lane 1 contained 7 μL Tri-dye ladder;
lane 2 contained 5 μL D37A PCR product and 2 μL 6X DNA loading buffer; lane 3
contained 5 μL E42A PCR product and 2 μL 6X DNA loading buffer. Both D37A and
E42A PCR products appeared as bands at approximately 4 kb, indicating successful PCR.

Figure 7: Successful generation of E95A Rv2633c PCR product

E95A Rv2633c mutant PCR product was visualized using a 0.8% agarose gel to
confirm successful PCR. From left, lane 1 contained 7 μL Tri-dye ladder, and lane 2
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contained 5 μL E97A PCR product and 2 μL 6X DNA loading buffer. E95A PCR
product appeared as a band at approximately 4 kb, indicating successful PCR.
Figure 8: Successful generation of ΔI122-I161 Rv2633c PCR product

ΔI122-I161 mutant Rv2633c PCR product was visualized using a 0.8% agarose
gel to confirm successful PCR. From left, lane 1 contained 7 μL Tri-dye ladder, and lane
2 contained 5 μL ΔI122-I161 PCR product and 2 μL 6X DNA loading buffer. ΔI122-I161
PCR product appeared as a band at approximately 4 kb, indicating successful PCR.
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Figure 9: Expression and native purification of wild-type Rv2633c

Wild-type Rv2633c was expressed and purified using cobalt affinity
chromatography. Each step of the purification was visualized using 12% SDS-PAGE to
assess purity and solubility of eluted wild-type Rv2633c. Consistent with previous
reports, wild-type Rv2633c eluted as a soluble 18 kDa protein. Lanes 2-7 on the left gel
and lanes 1-9 on the right gel were loaded with 5 μL from a mixture of 8 μL sample and
32 μL SDS loading buffer. Lanes 8-10 on the left gel were loaded with 5 μL SDS loading
buffer to prevent uneven migration of bands through the gel. Slight contamination is
visible in elution samples 2 and 3, but did not noticeably affect the absorbance spectrum
(Figure 12).
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Figure 10: Expression and native purification of E95A Rv2633c

E95A Rv2633c was expressed and purified using cobalt affinity chromatography,
using the same protocol as the purification of wild-type Rv2633c (Figure 9). Each step of
the purification was visualized using 12% SDS-PAGE to assess purity and solubility of
eluted E95A Rv2633c. Similar to wild-type Rv2633c, E95A Rv2633c eluted as a soluble
18 kDa protein. Lanes 2-6 on the left gel and lanes 1-10 on the right gel were loaded with
5 μL from a mixture of 8 μL sample and 32 μL SDS loading buffer. Lane 1 on the left gel
was loaded with 5 μL pre-stained Spectra Broad-Range protein ladder. E95A soluble
lysate was used as a ladder on the right gel. Lanes 7-10 on the left gel were loaded with 5
μL SDS loading buffer to prevent uneven migration of bands through the gel. No
contaminants were visible in the elution lanes, even after magnification of a highresolution image.
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Figure 11: ΔI122-I161 Rv2633c did not elute as a soluble protein

ΔI122-I161 Rv2633c was expressed and purified using cobalt affinity
chromatography, using the same protocol as the purification of wild-type and E95A
Rv2633c (Figures 9, 10). However, unlike wild-type and E95A Rv2633c, ΔI122-I161
Rv2633c did not elute as a soluble protein. From left, lanes 2-9 were loaded with 6 μL
from a mixture of 8 μL sample and 32 μL SDS loading buffer. Lane 1 was loaded with 6
μL pre-stained Spectra Broad Range protein ladder. Lane 10 was loaded with 6 μL SDS
loading buffer to prevent uneven migration of bands through the gel.
The lack of soluble ΔI122-I161 Rv2633c may be due to aggregation or misfolding
caused by the C-terminal deletion. While SWISS-MODEL predicted that the deleted
region of Rv2633c was positioned separately from the rest of the protein, it is possible
that this model is incorrect. The ΔI122-I161 mutation may have disrupted the overall
structure of Rv2633c, leading to aggregation or misfolding.
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Figure 12: Rv2633c exhibited varying iron content based on UV-vis spectra

The UV-vis spectrum of E95A was analyzed and compared to the spectrum of
wild-type Rv2633c to determine iron content. Each purified Rv2633c was dialyzed into
20 mM HEPPS to remove residual imidazole before spectral analysis. Presence of the
iron cofactor was indicated by a broad absorbance from 300-360 nm. While wild-type
Rv2633c normally exhibits this absorbance pattern, this preparation of wild-type
Rv2633c did not. Previous attempts to purify Rv2633c indicate that the iron content is
inconsistent, even between replicates using the same purification protocol. E95A
Rv2633c may contain iron, but possibly not to the same degree as wild-type Rv2633c
typically does (Figure 13). However, due to the inconsistent nature of iron content in
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Rv2633c, it is difficult to draw conclusions about the iron content of the E95A mutant
based on a single preparation.

Figure 13: Rv2633c previously exhibited a broad absorbance indicative of iron
content

As reported in 2017, wild-type Rv2633c typically exhibits a broad absorbance
from 300-360 nm, which is indicative of the iron cofactor in a hemerythrin-like protein
[13]. While E95A Rv2633c exhibited a similar absorbance pattern, it was between 300
and 450 nm instead of the characteristic 300-360 nm absorbance pattern shown above.
The lengthened absorbance in this preparation of E95A Rv2633c may be due to cobalt
resin that passed through the base of the gravity column during elution.
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DISCUSSION
Based on the finding that wild-type Rv2633c elutes as a soluble protein (figure 9),
it is interesting that the C-terminal truncation mutant is not soluble (figure 10). This
difference may indicate that the deleted region of amino acids at the C terminus leads to
aggregation or improper folding of Rv2633c. This region was projected by SWISSMODEL to fold into a discrete alpha helix, separate from the rest of the protein, but it is
possible that this projection is inaccurate. The degree of homology between Rv2633c and
NMB1532, the protein used to generate the predicted structure of Rv2633c, is only 18%,
so it is not surprising that this model of Rv2633c structure may be inaccurate.
Perhaps the structure of Rv2633c more closely resembles Ytfe, an iron-sulfur
cluster repair protein that SWISS-MODEL determined had the second-highest level of
structural homology to Rv2633c. When Ytfe is used as the structural template for
Rv2633c, only four alpha helices are present instead of five. The C-terminal truncation
would then delete part of the fourth alpha helix, interfering with the symmetry of the
protein as a whole. Further replicates of purification may be necessary to confirm that the
deleted section of the C-terminus is indeed required for folding in Rv2633c. While this is
an interesting finding, it does not answer the original question of whether the C-terminus
is involved in dimerization. This question may be answered by deleting fewer amino
acids from the C-terminal end of Rv2633c, because this new construct may be less likely
to aggregate or misfold.
The point mutation E95A eluted as a soluble protein, which was expected because
the point mutation was unlikely to cause major structural changes in Rv2633c. Past
experiments have shown that even when a point mutation causes Rv2633c to lose its iron
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cofactor, Rv2633c is still soluble. However, it is surprising that the UV-vis spectra in this
study differ in iron content from the previously reported UV-vis spectrum of wild-type
Rv2633c. Previous attempts at Rv2633c purification indicate that the iron content
fluctuates drastically between purifications, even when identical protocols are used. This
indicates that the findings in this study may not represent an accurate picture of Rv2633c
iron content, since each mutant was only purified once. Despite this uncertainty, it is
promising that the E95A mutant appears to contain less iron cofactor than the previously
reported iron content of wild-type Rv2633c. This may indicate that residue E95 is
involved in stabilization of the iron cofactor, despite being outside the HHE domain that
normally coordinates iron.
In addition to establishing the iron content of E95A Rv2633c, further studies may
analyze this mutant’s catalase activity. The variability in iron content and in protein
stability has proven difficult in both wild type and mutant forms of the protein. Ideal
protein expression conditions and purification is an ongoing part of the research with this
family of proteins.
As a whole, these results contribute to further biochemical characterization of
Rv2633c, the first example of a non-heme di-iron catalase. Further research about the
regulation and behavior of this protein is important in order to understand how Mtb
thrives inside the macrophage. Research in this area may reverse the trend of multi-drug
resistant TB and develop an effective vaccine.
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